The impact of the pandemic on alcohol-related liver disease and liver transplantation, and the emergence of non-alcohol related fatty liver disease (NAFLD) as a public health threat to be featured at International Liver Congress™ 2022 (ILC 2022)

The latest and 57th iteration of International Liver Congress™  (ILC 2022) returns as an in-person event in London this coming June (22–26). The event is being held at the ExCeL London exhibition centre, and […]

Weiterlesen

A-TANGO – An EU-funded clinical Phase II study gives cirrhosis patients new hope

More than ten million people worldwide suffer from decompensated cirrhosis, often as a result of severe alcoholic hepatitis (sAH) or other chronic liver diseases. In its final stages, decompensated cirrhosis […]

Weiterlesen